Basic information
The International Journal of Cardiovascular Sciences (Int. J. Cardiovasc. Sci.) is published by the Sociedade Brasileira de Cardiologia (Brazilian Society of Cardiology), and is issued on a bimonthly basis. Launched in 2015, this journal follows the previous ones, Revista da SOCERJ and Revista Brasileira de Cardiologia, created in 1998 and 2010, respectively. It is available in the online English version. Its abbreviated title is Int. J. Cardiovasc. Sci., which should be used in bibliographies, footnotes and bibliographical references and strips. |
Disclosure
Indexed in
The journal is indexed by:
|
Intellectual property
All content of the journal, except where identified, is licensed under a Creative Commons attribution type BY. This work is licensed under a Creative Commons Attribution 4.0 International License. CC BY - You are free to: Share - copy and redistribute the material in any medium or format, Adapt - remix, transform, and build upon the material for any purpose, even commercially. |
Sponsors
Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)
|
Editor-in-chief
|
SBC Scientific Committee
|
Editorial Board – ABC Family
|
Associate editors
|
Editorial comission
Brazil
Exterior
|
Editorial production
Arquivos Brasileiros de Cardiologia
Avenida Marechal Câmara, 160 - 3rd floor - Room 330 - Brazilian Society of Cardiology
Avenida Marechal Câmara, 160 - 3rd floor - Room 330 - 20020-907, Centro, Rio de Janeiro, RJ, Brazil. Tel: (21) 3478-2700 Editorial Production: SBC - Scientific Management - Internal Publications Center. Graphic Design and Layout - SBC - Department Communication and Marketing Department - Internal Design |
Why publishing in IJCS?
Open Science The term open science refers to a scientific practice model that is in line with the digital evolution that proposes the availability of information in web environments, as opposed to laboratory-confined research.1 The practice of open science involves the publication of research data, speedy editorial and communication processes through continuous publication of manuscripts and preprints, greater transparency in review processes and communication flows, and the pursuit of more comprehensive systems of review of manuscripts and journals.2,3 Preprint A preprint is a complete scientific manuscript that the authors place in a public server. Preprints contain complete data and methodologies. They are published on the web within one day approximately, without peer review, and can be viewed for free by anyone in the world, on platforms currently developed for this purpose, allowing scientists to directly control the promotion of their work for the scientific community around the world. In most cases, the same work published as preprint is also submitted for peer review in a journal. Therefore, preprints (not validated by peer review) and the publication of journals (validated by peer review) work in parallel as a communication system for scientific research.4,5 Submitting a manuscript to a preprint platform is not considered double publishing. Submitted articles cannot have been previously published elsewhere, either in whole or in part, in the form of either book chapters or journal papers. Neither can they be simultaneously submitted to other journals. Manuscripts previously published in scientific conference proceedings, preprint platforms, as preliminary versions or working papers, are considered unpublished for these purposes. Authors of manuscripts previously published on preprint servers must inform their online location (link, DOI etc.). They will be submitted to a blind review, in which reviewers are informed of authors’ identities. Manuscripts not previously published on preprint servers, on the other hand, go through a double-blind review, in which neither reviewers nor authors know each other’s identities. Comments received by manuscripts in preprints can be considered by editors during the peer review. If the author of a manuscript that is in peer review at IJCS wants to deposit it on a preprint server, he/she must request the journal's authorization through an e-mail: revistaijcs@cardiol.br. See below the complete list of preprints servers accepted by the journal:
Accepted manuscripts previously published in preprint platforms must include a link to the version published in IJCS. The journal IJCS seeks to keep its platform and rules constantly updated, in keeping with the practices of modern scientific publication. Today, we accept preprints and open science platforms to encourage communication among authors. Sources: |
Contents of manuscripts
TYPES OF MANUSCRIPTS Original Article: The journal IJCS accepts all types of original cardiovascular research, including research in humans and experimental research. Clinical trials should follow specific recommendations. Note: Systematic analyses and meta-analyses are considered original manuscripts, not reviews. Review Article: The editors send out invitations for most reviews. However, high-level studies conducted by authors or groups with previous publications on the subject will be welcome. In this section, any manuscripts whose main author does not have a comprehensive academic or publication background verified by Lattes (CNPQ), PubMed or SciELO will not be accepted. Note: Systematic analyses and meta-analyses are considered original manuscripts, not reviews. Viewpoint: It presents the authors’ stance or opinion on a specific scientific theme. This stance or opinion must be sufficiently corroborated by the literature or their personal experience. These aspects will be the basis of the opinion being issued. Case Report: Any cases including original descriptions of clinical observations or representing the originality of a given diagnosis or treatment or illustrating situations that do not occur very often in the clinical practice, which deserve a deeper understanding and more attention from cardiologists. Brief Communication: Original experiences whose relevance to the knowledge of a subject justifies the presentation of initial data of small series, or partial data of clinical trials. Editorial: Subjects or manuscripts critically addressed by a subject-matter specialist. All IJCS editorials are published upon invitation. We will not accept editorials submitted spontaneously. Letter to the Editor: Correspondence of scientific content related to manuscripts published in IJCS and evaluated for publication two months before. The authors of the original manuscript will be invited to respond. |
Organization of manuscript and technical standards
ORIGINAL ARTICLE 1 - First page/Cover page
2 - Abstract
3 - Body of the Manuscript It should be divided into five sections: introduction, methods, results, discussion and conclusions. Introduction:
Methods:
Results:
Discussion:
Conclusions:
4 - Acknowledgements
5 - Figures and Tables
6 - References
7 - Type of study
REVIEW ARTICLE 1 - First page/Cover page
2 - Abstract: No specific structure is required. A 250-word limit must be respected. 3 - Body of the manuscript: No specific structure is required. The word count must be respected. 4 - Acknowledgements:
5 - Figures and tables
6 - References
VIEWPOINT 1 - First page/Cover page
2 - Body of the manuscript: No specific structure is required. The word count must be respected. 3 - Acknowledgements
4 - Figures and tables
5 - References
CASE REPORT 1 - First page/Cover page
2 - Case Report: No specific structure is required. We suggest to include diagnostic hypotheses, description of the methods, a conclusion with the outcome of the case, its relevance and a final message. The word count must be respected. 3 - Acknowledgements:
4 - Figures and tables
5 - References
BRIEF COMMUNICATION 1 - First page/Cover page
2 - Abstract: No specific structure is required. A 250-word limit must be respected. 3 - Body of the manuscript: No specific structure is required. The word count must be respected. The manuscript must contain data or initial experiments of a scientific investigation. 4 - Acknowledgements:
5 - Figures and tables
6 - References
EDITORIAL 1 - First page/Cover page
2 - Body of the manuscript: No specific structure is required. The word count must be respected. 3 - Acknowledgements:
4 - Figures and tables
5 - References
1 - First page/Cover page
2 - Body of the manuscript: No specific structure is required. The word count must be respected. Note: The author of the referenced article will be contacted for a response. 3 - Figures and tables
4 - References
The authors can submit supplementary material attached to their manuscript, the publication of which will be online only if there is not enough space to include it in the printed article. The supplementary material must be relevant to the understanding and interpretation of the manuscript and must not repeat information from the printed article. The inclusion of supplementary material - which must be original and unpublished – must be limited and reasonable. The supplementary material will undergo editorial and peer review along with the main manuscript. If the manuscript is accepted for publication and if the supplementary material is considered suitable for publication by the editors, it will be published online upon publication of the manuscript as additional material provided by the authors. The material will not be edited or formatted, so the authors are responsible for the accuracy and presentation of the entire material. Each supplementary material must be identified as such upon submission of the manuscript and cited in the manuscript. |
SUMMARY TABLE OF THE STRUCTURING OF ARTICLES |
|||||||
|
GROUP 1 |
GROUP 2 |
GROUP 3 |
||||
Type of manuscript |
Original Article |
Review Article |
Viewpoint |
Case Report |
Brief Communication |
Editorial |
Letter to the Editor |
Maximum number of authors |
unlimited |
unlimited |
8 |
6 |
8 |
3 |
3 |
Title (characters including spaces) |
150 |
150 |
150 |
150 |
150 |
150 |
150 |
Running Title (characters including spaces) |
50 |
50 |
50 |
50 |
50 |
50 |
50 |
Abstract (maximum number of words) |
250 |
250 |
NA |
NA |
250 |
NA |
NA |
Body text (maximum number of words) |
5000* |
6500* |
5000* |
1500* |
1500* |
1500* |
800* |
Suggested number of references |
40 |
80 |
20 |
10 |
10 |
15 |
5 |
Suggested number of tables, figures and video |
8 |
8 |
4 |
2 |
2 |
2 |
1 |
*The accounting described takes into account: Title, short title, keywords, abstract, text, references and figure captions. |
|||||||
NA = not applicable |
Required documents for approved manuscripts
Original Article, Review Article, Viewpoint, Case Report, Brief Communication: 1 - Author’s online registration in the submission system: Registration details, ORCiD number, pre-print usage information (if used). ORCiD: The ORCiD (Open Researcher and Contributor ID) is a unique, free and persistent digital identifier that distinguishes one scholar/researcher from another and solves the problem of the ambiguity and similarity of names of authors and individuals, replacing name variations with a single numeric code. To register your ORCiD ID, go to: https://orcid.org/register. 2 - Conflict of interest: Form filled out and signed by the first author, informing when there is any relationship between the authors and any public or private entity that could derive some conflict of interest. This information must be included in the end of the manuscript. Click. 3 - Author contribution form: Form filled out and signed by the first author stating the contributions of all participants. This information must be included in the end of the manuscript. Click. 4 - Copyrights: Form filled out and signed by all co-authors authorizing the transfer of copyrights. Click. 5 - Ethics: Form filled out and signed by the first author stating whether the research was approved by the Research Ethics Committee of their institution. Click.
Editorial, Letter to the editor, Short editorial: 1 - Author’s online registration in the submission system: Registration details, ORCiD number, pre-print usage information (if used). ORCiD: The ORCiD (Open Researcher and Contributor ID) is a unique, free and persistent digital identifier that distinguishes one scholar/researcher from another and solves the problem of the ambiguity and similarity of names of authors and individuals, replacing name variations with a single numeric code. To register your ORCiD ID, go to: https://orcid.org/register. 2 - Copyrights: Form filled out and signed by all co-authors authorizing the transfer of copyrights. Click. Types of study - Conformation for approval Clinical trial/experimental study (consort compliant) Reports of randomized trials must conform to the revised CONSORT guidelines and should be submitted with their protocols and a completed CONSORT checklist. All reports of clinical trials must include a summary of previous research findings and explain how the submittedtrial affects this summaryof previous findings. Cluster randomized trials should be reported according to extended CONSORT guidelines. Randomized trials reporting harms must be described according to extended CONSORT guidelines. All reports of randomized trials should include a section entitled “Randomization and masking” within the methods section. For information regarding CONSORT guidelines, please visit http://www.consort-statement.org. Observational study (strobe compliant) Observational research comprises several study designs and many topic areas. The STROBE statement should be used when reporting such research. The STROBE recommendations apply to the three main analytical designs usedin observational research: cohort, case-control, and cross-sectional studies. The STROBE statement consists of a 22-item checklist. For information regarding STROBE guidelines, please visit http://www.strobe-statement.org. *Please note that IJCS uses a customized version of the STROBE checklist, available only at http://www.editorialmanager.com/md in the “Files & Resources” section of the home page. Systematic review and meta-analysis (prisma compliant) Systematic reviews and meta-analyses must be reported according to PRISMA guidelines, an evidence-based minimum set of items createdto help authors improve the reporting of systematic reviews and meta-analyses. The PRISMA Statement consists of a 27-item checklist and a four-phase flow diagram. For information regarding PRISMA guidelines, please visit http://www.prisma-statement.org. Meta-analysis of observational studies in epidemiology (moose compliant) Systematic reviews and meta-analyses of observational studies in epidemiology should be reported according to MOOSE guidelines. For more information regarding MOOSE guidelines, please visit http://www.equator-network.org/reporting-guidelines/meta-analysis-of-observational-studies-in-epidemiology-a-proposal-for-reporting-meta-analysis-of-observational-studies-in-epidemiology-moose-group/. Diagnostic accuracy study (stard compliant) Investigators reporting studies of diagnostic accuracy should adhere to the STARD statement, partof the STARD initiative to improve the accuracy and completeness of reporting of studies of diagnostic accuracy, to allow readers to assess the potential for bias in astudy (internal validity) and to evaluate a study’sgeneralizability (external validity). The STARD statement consists of a 25-item checklist and recommends the use of a flow diagram to describe the design of the study and the flow of patients. For information regarding STARD guidelines, please visit http://www.stard-statement.org. Quality improvement study (squire compliant) The SQUIRE statement helpsauthors write excellent, usable articles about quality improvement in healthcare so that findings may be easily discovered and widely disseminated. The SQUIRE statement consists of a 19-itemchecklist. The SQUIRE guidelines are not exclusive of other guidelines. For example, an improvement project or effectiveness study that used a randomized controlled trial design should consider using both the CONSORT and the SQUIRE guidelines.In these cases, both checklists should be uploaded as a single document.For more information regarding SQUIRE guidelines, please visit http://squire-statement.org/. *Please note that IJCS uses a customized version of the SQUIRE checklist, available only at http://www.editorialmanager.com/md in the “Files &Resources” section of the home page. Economic evaluation study (cheers compliant) Developed by the ISPOR Quality Improvement in Cost-Effectiveness Research Task Force, the CHEERS statement supports the quality, consistency, and transparency of health economic and outcomes research reporting in the biomedical literature. The CHEERS statement includes a 24-item checklist. For more information regarding CHEERSguidelines, please visit http://www.ispor.org/taskforces/EconomicPubGuidelines.asp. Clinical case report (care compliant) The CARE guidelines provide a framework to support the need for completeness, transparency and data analysis in case reports and data from the point of care. The main tools of CARE are the CARE Statement, CARE checklist, and a Case Report Writing Template. These products offer a rationale and a standardized format for authors to prepare more complete and transparent case reports. For more information regarding CARE guidelines, please visit http://www.care-statement.org/. Ethics: human studies Studies on patients or volunteers must be receive ethics committee approval and informed consent, which should be documented in the paper, including the approval number. Patients have a right to privacy. Authors should remove information from photographs and manuscripts that might identify a patient. Where this is impossible, submissions must be accompanied by a written release from the patient. It is the author's responsibility to ensure that patients' privacy is protected. Authors should pay close attention to images that contain identifiable individual patient characteristics or data such as eyes, date of birth, case number, initials, birthmarks, etc. Informed consent should be obtained in writing from the patient if there is concern that a patient's anonymity cannot be maintained in written text or with use of photographs or video. Written consents must be provided to the editorial office on request. Even where consent has been given, identifying details should be omitted if they are not essential. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note. If such consent has not been obtained, personal details of patients included in any part of the paper and in any supplementary materials (including all illustrations and videos) must be removed before submission. Animal research and studies In experiments involving animals, the standards established in the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, National Academy of Sciences, Washington, D.C., 1996) and the Ethical Principles in Animal Experiments of the Brazilian Council of Animal Experimentation (COBEA) must be respected. Research must conform the following items: 1) animal care and use by qualified individuals, supervised by veterinarians, and all facilities and transportation must comply with current legal requirements and guidelines; 2) research involving animals should be done only when alternative methods to yield needed information are not possible; 3) anesthesia must be used in all surgical interventions, all unnecessary suffering should be avoided and research must be terminated if unnecessary pain or fear results; and 4) animal facilities must meet the international standards. SAGER GUIDELINES The IJCS journal recommends the application of the SAGER guidelines to all research with humans, animals or any material originating from humans and animals, as well as other disciplines whose results will be applied to humans, such as mechanics and engineering.
Access the full document of the SAGER guidelines. Exclusive submission/Publication policy Manuscripts are considered for review only under the conditions that they are not under consideration elsewhere and that the data presented have not been previously published (including symposia, proceedings, transactions, books, articles published by invitation, and preliminary publications of any kind, excepting abstracts that do not exceed 500 words). On acceptance, transfer of copyright to the International Journal of Cardiovascular Sciences must be provided. Relationship with industry policy – Conflict of interest exclusive All authors are required to disclose any relationship with industry and other relevant entities - financial or otherwise - within the past 2 years that might pose a conflict of interest in connection with the submitted article. All relevant relationships with industry, disclosures, and sources of funding for the work should be acknowledged on the title page, as should all institutional affiliations of the authors (including corporate appointments). This includes associations such as consultancies, stock ownership, or other equity interests or patent-licensing arrangements. If no relationship with industry exists, please state this on the title page. All forms are now signed and submitted electronically. Once a manuscript is accepted, form will be filled out and signed by the first author, informing when there is any relationship between the authors and any public or private entity that could derive some conflict of interest. This information must be included in the end of the manuscript. Click. Statistic guidelines Proper use of statistical methods as well as their correct description is of paramount importance for manuscripts published in IJCS. Therefore, some general guidelines apply to the information to be provided regarding statistical analysis (for further details, we suggest reading the European Heart Journal’s statistical guidelines).
Plagiarism Plagiarism policy for International Jounal of Cariovascular Sciences: Plagiarism is not accepted in IJCS. It compromises the true meaning of Science. Plagiarism is defined when an author attempts to use someone else work as his or her own. Another form of plagiarism is self-plagiarism, ou duplication: it occurs when an author reuses significant parts of his or her own published work without appropriate references. Plagiarism is a scientific misconduct and will be addressed as such. When plagiarism is detected at any time before publication, the editorial office will take appropriate action as directed by the standards set forth by the Committee on Publication Ethics (COPE). For additional information, please visit http://www.publicationethics.org. IJCS uses the iThenticate software to verifiy the originality of content submitted before publication. iThenticate checks submissions against millions of published research papers, and billions of web content. Authors, researchers and freelancers can also use iThenticate to screen their work before submission by visiting http://www.ithenticate.com. Plagiarism detect before publishing: IJCS editors will evaluate any case of plagiarism on its limits. If plagiarism is detected before publishing then we will inform the author(s) and will ask them to rewrite the content or use appropriate references from where the content has been taken. If more than 25% of the paper is plagiarized, then the article will be rejected and authors notified. How plagiarism is checked? All the submitted manuscripts for publication are checked for plagiarism with online tools after submission and before starting review. How is plagiarism handled? The manuscripts in which the plagiarism is detected are handled based on the extent of the plagiarism. 10-25% Plagiarism: The manuscript is sent back to the author for content revision without entering the review process. > 25% Plagiarism: The manuscript will be rejected without the entering the review process. The authors are advised to revise the manuscript and resubmit the manuscript. Plagiarism detection after publication If a case of plagiarism is detected after IJCS had published the article we will contact the author's institute and funding agencies. A determination of misconduct will lead the IJCS to publish a statement, linked online to and from the original paper, to note the plagiarism and to provide a reference to the plagiarised material. In severe cases (> 50% of plagiarism) the paper will be formally retracted. Word count limits The electronic word count should include the title, the cover page, abstract, text, references and figures/tables legends. |
Translation
* Authors’ translation 1- The author must submit the manuscript in English. 2- We advise everyone to have a professional review of English before sending, in case of necessary adjustments. |
**Translation organized by SBC
|
The review process
Submission To submit your manuscript, please visit https://mc04.manuscriptcentral.com/ijcs-scielo and register as an author. If you already have a reviewer login, you can use the same login. To submit your manuscript, please follow the steps below. |
Analysis IJCS uses a double-blind peer-review system, meaning that the reviewers of the paper will be blind to the identity of the author(s), and the author(s) will be blind to the identity of the reviewer. At initial submission, a manuscript is reviewed by editorial staff for compliance with journal style and to make sure the submission is clear and legible for reviewers and editors. Once the editorial staff have checked in the paper, it is assigned to the Editor-in-Chief, who will assign it to an Associate Editor. The Associate Editor then determines if it should be sent for peer review or if it is not of sufficient priority for JACC. All reviewers and editors are asked to report any potential conflicts of interest, and when those exist the manuscript is reassigned to a different editor or reviewer. The manuscripts are submitted to statistical review, whenever necessary. Once at least to 2 reviews have been completed, the submission is reviewed by the associate editors and Editor-in-chief, who come to one of the five decisions below. Reviewers have 30 days to review the manuscript.
Approval 1. Acceptance will be based on originality, significance and scientific contribution to the body of knowledge in the area. 2. The final formatted version (English) will be sent to the author, who must return it within 5 days with minimal spelling adjustments. If the author does not respond in 5 days, these will be considered the final versions for publication. Publication After the author’s approval, the versions are sent to indexation, when the DOI and the XML versions for the main indexers are generated. The manuscript will be allocated to a volume and an issue, and published online on the journal website (PDF and HTML). |
Publication ethics and publication malpractice statement
The International Journal of Cardiovascular Sciences (IJCS) follows the Code of Conduct and Best Practice Guidelines for Journal Editors (Code of Conduct and Best Practice Guidelines for Journal Editor), established by the Committee on Publication Ethics (COPE). In addition, as a journal that follows the ICMJE (International Committee of Medical Journal Editors)’s Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals, it is expected of authors, reviewers and editors that they follow the best-practice guidelines on ethical behaviour contained therein. Below is a selection of key points that can be consulted in full by accessing the three documents listed above. 1. Duties of Editors Fair play and editorial independence Editors evaluate submitted manuscripts exclusively on the basis of their academic merit (importance, originality, study’s validity, clarity) and its relevance to the journal’s scope, without regard to the authors’ race, gender, sexual orientation, ethnic origin, citizenship, religious belief, political philosophy or institutional affiliation. Decisions to edit and publish are not determined by the policies of governments or any other agencies outside of the journal itself. The Editor-in-Chief has full authority over the entire editorial content of the journal and the timing of publication of that content. Confidentiality Editors and editorial staff will not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate. Disclosure and conflicts of interest Editors and editorial board members will not use unpublished information disclosed in a submitted manuscript for their own research purposes without the authors’ explicit written consent. Privileged information or ideas obtained by editors as a result of handling the manuscript will be kept confidential and not used for their personal advantage. Editors will recuse themselves from considering manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships/connections with any of the authors, companies or institutions connected to the papers; instead, they will ask another member of the editorial board to handle the manuscript. Publication decisions The editors ensure that all submitted manuscripts being considered for publication undergo peer-review by at least two reviewers who are expert in the field. The Editor-in-Chief is responsible for deciding which of the manuscripts submitted to the journal will be published, based on the validation of the work in question, its importance to researchers and readers, the reviewers’ comments, and such legal requirements as are currently in force regarding libel, copyright infringement and plagiarism. The Editor-in-Chief may confer with other editors or reviewers in making this decision. Involvement and cooperation in investigations Editors (in conjunction with the publisher and/or society) will take responsive measures when ethical concerns are raised with regard to a submitted manuscript or published paper. Every reported act of unethical publishing behaviour will be looked into, even if it is discovered years after publication. IJCS editors follow the COPE Flowcharts when dealing with cases of suspected misconduct. If, on investigation, the ethical concern is well-founded, a correction, retraction, expression of concern or other note as may be relevant, will be published in the journal. 2. Duties of Reviewers Contribution to editorial decisions Peer review assists editors in making editorial decisions and, through editorial communications with authors, may assist authors in improving their manuscripts. Peer review is an essential component of formal scholarly communication and lies at the heart of scientific endeavour. IJCS shares the view of many that all scholars who wish to contribute to the scientific process have an obligation to do a fair share of reviewing. Promptness Any invited referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should immediately notify the editors and decline the invitation to review so that alternative reviewers can be contacted. Confidentiality Any manuscripts received for review are confidential documents and must be treated as such; they must not be shown to or discussed with others except if authorized by the Editor-in-Chief (who would only do so under exceptional and specific circumstances). This applies also to invited reviewers who decline the review invitation. Standards of objectivity Reviews should be conducted objectively and observations formulated clearly with supporting arguments so that authors can use them for improving the manuscript. Personal criticism of the authors is inappropriate. Acknowledgement of sources Reviewers should identify relevant published work that has not been cited by the authors. Any statement that is an observation, derivation or argument that has been reported in previous publications should be accompanied by the relevant citation. A reviewer should also notify the editors of any substantial similarity or overlap between the manuscript under consideration and any other manuscript (published or unpublished) of which they have personal knowledge. Disclosure and conflicts of interest Any invited referee who has conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies or institutions connected to the manuscript and the work described therein should immediately notify the editors to declare their conflicts of interest and decline the invitation to review so that alternative reviewers can be contacted. Unpublished material disclosed in a submitted manuscript must not be used in a reviewer’s own research without the express written consent of the authors. Privileged information or ideas obtained through peer review must be kept confidential and not used for the reviewer’s personal advantage. This applies also to invited reviewers who decline the review invitation. 3. Duties of Authors Reporting standards Authors of original research should present an accurate account of the work performed and the results, followed by an objective discussion of the significance of the work. The manuscript should contain sufficient detail and references to permit others to replicate the work. Review articles should be accurate, objective and comprehensive, while viewpoints should be clearly identified as such. Fraudulent or knowingly inaccurate statements constitute unethical behaviour and are unacceptable. Data access and retention Authors may be asked to provide the raw data of their study together with the manuscript for editorial review and should be prepared to make the data publicly available if practicable. In any event, authors should ensure accessibility of such data to other competent professionals for at least 10 years after publication (preferably via an institutional or subject-based data repository or other data centre), provided that the confidentiality of the participants can be protected and legal rights concerning proprietary data do not preclude their release. Originality and plagiarism Authors should ensure that they have written and submit only entirely original works, and if they have used the work and/or words of others, that this has been appropriately cited. Publications that have been influential in determining the nature of the work reported in the manuscript should also be cited. Plagiarism takes many forms, from "passing off" another's paper as the author's own, to copying or paraphrasing substantial parts of another's paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical publishing behaviour and is unacceptable. Multiple, duplicate, redundant or concurrent submission/publication Papers describing essentially the same research should not be published in more than one journal or primary publication. Hence, authors should not submit for consideration a manuscript that has already been published in another journal. Submission of a manuscript concurrently to more than one journal is unethical publishing behaviour and unacceptable. The publication of some kinds of articles (such as clinical guidelines, translations) in more than one journal is sometimes justifiable, provided that certain conditions are met. The authors and editors of the journals concerned must agree to the secondary publication, which must reflect the same data and interpretation of the primary document. The primary reference must be cited in the secondary publication. Authorship of the manuscript Only persons who meet these authorship criteria should be listed as authors in the manuscript as they must be able to take public responsibility for the content: (i) made significant contributions to the conception, design, execution, data acquisition, or analysis/interpretation of the study; and (ii) drafted the manuscript or revised it critically for important intellectual content; and (iii) have seen and approved the final version of the paper and agreed to its submission for publication. All persons who made substantial contributions to the work reported in the manuscript (such as technical help, writing and editing assistance, general support) but who do not meet the criteria for authorship must not be listed as an author, but should be acknowledged in the "Acknowledgements" section after their written permission to be named as been obtained. The corresponding author should ensure that all appropriate coauthors (according to the above definition) and no inappropriate coauthors are included in the author list and verify that all coauthors have seen and approved the final version of the manuscript and agreed to its submission for publication. Disclosure and conflicts of interest Authors should – at the earliest stage possible (generally by submitting a disclosure form at the time of submission and including a statement in the manuscript) – disclose any conflicts of interest that might be construed to influence the results or their interpretation in the manuscript. Examples of potential conflicts of interest that should be disclosed include financial ones such as honoraria, educational grants or other funding, participation in speakers’ bureaus, membership, employment, consultancies, stock ownership, or other equity interest, and paid expert testimony or patent-licensing arrangements, as well as non-financial ones such as personal or professional relationships, affiliations, knowledge or beliefs in the subject matter or materials discussed in the manuscript. All sources of financial support for the work should be disclosed (including the grant number or other reference number if any). Acknowledgement of sources Authors should ensure that they have properly acknowledged the work of others, and should also cite publications that have been influential in determining the nature of the reported work. Information obtained privately (from conversation, correspondence or discussion with third parties) must not be used or reported without explicit, written permission from the source. Authors should not use information obtained in the course of providing confidential services, such as refereeing manuscripts or grant applications, unless they have obtained the explicit written permission of the author(s) of the work involved in these services. Hazards and human participants or use of animals If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the authors must clearly identify these in the manuscript. If the work involves the use of animals or human participants, the authors should ensure that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) has approved them; the manuscript should contain a statement to this effect. Authors should also include a statement in the manuscript that informed consent was obtained for experimentation with human participants. The privacy rights of human participants must always be observed. Peer review Authors are obliged to participate in the peer review process and cooperate fully by responding promptly to editors’ requests for raw data, clarifications, and proof of ethics approval, patient consents and copyright permissions. In the case of a first decision of "revisions necessary", authors should respond to the reviewers’ comments systematically, point by point, and in a timely manner, revising and re-submitting their manuscript to the journal by the deadline given. Fundamental errors in published works When authors discover significant errors or inaccuracies in their own published work, it is their obligation to promptly notify the journal’s editors or publisher and cooperate with them to either correct the paper in the form of an erratum or to retract the paper. If the editors or publisher learns from a third party that a published work contains a significant error or inaccuracy, then it is the authors’ obligation to promptly correct or retract the paper or provide evidence to the journal editors of the correctness of the paper. 4. Duties of the Publisher Handling of unethical publishing behaviour In cases of alleged or proven scientific misconduct, fraudulent publication or plagiarism, the Brazilian Society of Cardiology (Sociedade Brasileira de Cardiologia – SBC), journal's publisher, in close collaboration with the editors, will take all appropriate measures to clarify the situation and to amend the article in question. This includes the prompt publication of an erratum, clarification or, in the most severe case, the retraction of the affected work. The publisher, together with the editors, shall take reasonable steps to identify and prevent the publication of papers where research misconduct has occurred, and under no circumstances encourage such misconduct or knowingly allow such misconduct to take place. Access to journal content The SBC is committed to the permanent availability and preservation of scholarly research and ensures accessibility by partnering with organizations and maintaining our own digital archive. |